Newsletter Writers
A
- Oz Adler Therapix Biosciences Ltd.
- Sanjiv S. Agarwala, MD St Lukes Hospital & Health Network Temple University
- Michael Aitkenhead Edison Investment Research
- Jay Albany SeeThruEquity
- Michael Altman Perceptive Advisors LLC
- Daniel Ameduri FutureMoneyTrends.com
- Ashim Anand Natixis Securities Americas
- Ben Andrew William Blair
- Matthew Andrews Wells Fargo & Co.
- Bill Annett OncoCyte Corporation
- Danielle Antalffy Leerink Partners LLC
- Ed Arce H.C. Wainwright & Co.
- Alex Arfaei BMO Capital Markets
- Daniel Arias Citigroup
- Catherine Arnold Wellington Management
- Dr. Jonathan Aschoff ROTH Capital Partners
- Jocelyn August Sagient Research
- David Aviezer
B
- Saeid Babaei BriaCell Therapeutics Corp.
- Andrea Bartzen
- David Bautz Zacks Small-Cap Research
- Bob Bechard Tetra Bio-Pharma Inc.
- Tom Beck Portfolio Wealth Global
- Michael Becker Relmada Therapeutics Inc.
- Serge Belanger Needham & Co
- Reni Benjamin Raymond James
- Vernon Bernardino H.C. Wainwright & Co.
- Michael Berry Disruptive Discoveries Journal
- Arthur Bertolino Innovation Pharmaceuticals (Formerly known as Cellceutix Corp.)
- Steve Beuchaw Morgan Stanley
- Amit Bhalla Citigroup
- Larry Biegelsen Wells Fargo & Co.
- Jim Birchenough Wells Fargo & Co.
- Charles Bisgaier Gemphire Therapeutics
- Ray Blanco Agora Financial
- Joe Bleackley Friday Night Inc.
- Jonathan Block SunTrust Robinson Humphrey
- Brian Bloom Bloom Burton & Co.
- Bill Bonello Craig-Hallum Capital
- Matt Bottomley Canaccord Genuity
- Richard Brand BeyondSpring Pharmaceuticals Inc.
- Mark Breidenbach Oppenheimer & Co.
- Dan Brennan TD Cowen
- Francois Brisebois Oppenheimer & Co.
- Alan Brochstein
- Bryan Brokmeier Cantor Fitzgerald
- Sheila Broughton PI Financial
- Jim Brown DURECT Corp.
- Steve Brozak WBB Securities
- Karen Bulock RXi Pharmaceuticals Corp.
- Robert Burns H.C. Wainwright & Co.
- Jason Butler JMP Securities
- Anthony Butler Guggenheim Partners
C
- Nathan Cali Noble Financial
- Jennifer Cameron
- Bruce Campbell Stonecastle Investment Management
- Vered Caplan Orgenesis Inc.
- Alan Carr Needham & Co
- Geert Cauwenbergh RXi Pharmaceuticals Corp.
- Dalton Chandler
- Debjit Chattopadhyay Guggenheim Securities LLC
- Sam Chawla Perceptive Advisors LLC
- Dr. Yi Chen H.C. Wainwright & Co.
- Steve Chesney Redburn Atlantic
- Gregory Chodaczek Sterne Agee
- Greg Chodaczek
- Wang Chong Edison Investment Research
- Heather Clarke IMV Inc.
- Hugh Cleland Roadmap Capital Inc.
- Richard Close Canaccord Genuity
- Jeff Cohen Ladenburg Thalmann
- Mick Cooper Edison Investment Research
- Caroline Corner Cantor Fitzgerald
- Mario Corso
- David Cory Eiger BioPharmaceuticals
- Patrick Cox Mauldin Economics
- Lisa Crossley
- Steven Crowley
- Rick Currin Currin Biotech
- Frank Curzio Phase 1 Investor Stansberry Research
- Adam Cutler Molecular Templates
D
- Alex Daley
- Steven Davidson Agility Health Inc.
- Corey Davis H.C. Wainwright & Co.
- Robin Davison Edison Investment Research
- John Dawson Oxford Biomedica Plc
- Ronald Day
- Derik de Bruin Bank of America Merrill Lynch
- Jan De Kerpel KBC Securities
- Pete de Spain Kura Oncology Inc.
- Jonathan DeCourcey Viridian Capital Advisors
- Shaunak Deepak H.C. Wainwright & Co.
- Kevin DeGeeter Ladenburg Thalmann
- Rik Deitsch Nutra Pharma Corp.
- Domenic Della Penna Intellipharmaceutics International Inc.
- Sara Demy Demy-Colton Life Science Advisors ZZ_Demy-Coulton, Life Science Advisors
- Ivan Deryugin Seeking Alpha
- Francis DeSouza Illumina Inc.
- Punit Dhillon OncoSec Medical Inc.
- Hunter Diamond Diamond Equity Research
- Gerrit Dispersyn RXi Pharmaceuticals Corp.
- Vamil Divan Credit Suisse
- Matthew Dodds Citigroup
- Patrick Dolezal LifeSci Capital
- "Bob" Robert Doody Idera Pharmaceuticals
- Charles Duncan Cantor Fitzgerald
- Stephen Dunn LifeTech Capital
- Matthew During Ovid Therapeutics Inc.
- Cameron Durrant Humanigen Inc.
- Anita Dushyanth Zacks Investment Research
E
- Jonathan Eckard Citigroup
- Leo Ehrlich Innovation Pharmaceuticals (Formerly known as Cellceutix Corp.)
- Hossein Ekrami Perceptive Advisors LLC
- Alexey Eliseev
- Laura Engel
- Pierre Erwes BioMarine Organization Limited
F
- Jeremy Feffer
- Andrew Fein H.C. Wainwright & Co.
- Adam Feinstein Barclays
- David Fellows Nightstar Therapeutics Plc
- Akiva Felt Oppenheimer & Co.
- Seamus Fernandez Leerink Partners LLC
- Tony Fiorino
- Pnina Fishman Can-Fite BioPharma Ltd.
- Harry Fleming Nobilis Health Corp.
- Philippa Flint
- Dorman Followwill Frost & Sullivan Inc
- Jeffrey Frelick
- David Friedman Morgan Stanley
- Jolene Furdek Edison Investment Research
G
- Kristen Galfetti
- Angelita Garcia OncoSec Medical Inc.
- Philippa Gardner Edison Investment Research
- Ronald Garren Biotech Insights
- Jeff Garro William Blair
- Andrew Gengos ImmunoCellular Therapeutics Ltd.
- Katherine Genis Trinity Delta
- Gregg Gilbert Bank of America Merrill Lynch
- Steve Gilman ContraFect Corp.
- Christian Glennie Edison Investment Research
- Richard Glickman Aurinia Pharmaceuticals Inc.
- Nick Glover Sierra Oncology
- Michael Goldberg Navidea Biopharmaceuticals Inc.
- Elliot Goldstein ProMIS Neurosciences Inc.
- Mara Goldstein Cantor Fitzgerald
- Marc Goodman UBS Securities
- Jack Gorman Davy Research
- Dhesh Govender Cedar Lane Fund
- Prakash Gowd CIBC World Markets
- William Gregozeski Mont Blanc Capital Management
- Adam Grossman ADMA Biologics Inc.
- Steve Gullans Gemphire Therapeutics
- Thomas Gunderson Piper Jaffray & Co.
H
- Saul Hadassin Credit Suisse
- Charles Haff Boston Scientific Corp.
- J.T. Haresco JMP Securities
- Robert Hariri Celgene Corp.
- Mike Havrilla BioRunUp
- Michael Hay Sagient Research
- Ben Haynor Lake Street Capital Markets
- Amit Hazan SunTrust Robinson Humphrey
- Bert Hazlett Ladenburg Thalmann
- Echo He
- Pooya Hemami Edison Investment Research
- Scott Henry ROTH Capital Partners
- Heidi Henson Kura Oncology Inc.
- Noelle Herber Advaxis Inc.
- Ori Hershkovitz Sphera Fund Management
- John Hester Bell Potter Securities Ltd
- Michael Higgins Ladenburg Thalmann
- Keith Hinton Sidoti & Company
- Matt Hogan
- Dr. Stuart Holden UCLA David Geffen School of Medicine
- Bob Hopkins Merrill Lynch
- Andrew Hopkins Vical Inc.
- Doug Hornig Casey Research
- Lan Huang BeyondSpring Pharmaceuticals Inc.
- Richard Huebner GVC Capital
- Ellen Hukkelhoven Perceptive Advisors LLC
- Dennis Hulme Edison Investment Research
- Junaid Husain Dougherty & Company LLC
I
- Stephen Ireland Roadmap Capital Inc.
- Jerry Isaacson LifeSci Advisors LifeSci Capital
- Silviu Itescu
J
- Bruce Jackson The Benchmark Company LLC
- Scott Jackson Celator Pharmaceuticals Inc.
- Maxim Jacobs Edison Investment Research
- Christopher James Corcept Therapeutics Inc.
- Rajeev Jashnani UBS Securities
- Rahul Jasuja Noble Financial
- Dr. Yale Jen Laidlaw & Company
- Josh Jennings Cowen & Co.
- Peter Johann NGN Capital LLC
- Andrew Johnson ChromaDex Corp.
- Charley Jones Barrington Research
- Robert Jones Goldman Sachs
- Drew Jones Stephens Inc.
- Daniel Jorgensen Innovation Pharmaceuticals (Formerly known as Cellceutix Corp.)
- James Joyce Aethlon Medical Inc.
K
- Margaret Kaczor William Blair
- David Kalergis Diffusion Pharmaceuticals Inc.
- Suraj Kalia Northland Securities
- Chris Kallos Edison Investment Research
- Jason Kantor Credit Suisse
- Matthew Kaplan Ladenburg Thalmann
- Jayne Kauffman Infinity Pharmaceuticals Inc.
- Tucker Kelly Deciphera Pharmaceuticals Inc.
- Geert Kersten CEL-SCI Corporation
- Mark Kessel Symphony Capital LLC
- Lennox Ketner Merrill Lynch
- Lawrence Keusch Morgan Keegan
- Zarak Khurshid
- David Kideckel Beacon Securities Ltd.
- Stephen Kilmer
- J. Joseph Kim Inovio Pharmaceuticals Inc.
- Michael G. King, Jr. H.C. Wainwright & Co.
- Tracy Kinjerski Avid Bioservices Inc.
- Brian Klein Stifel
- Jason Kolbert D. Boral Capital
- Chris Kroeger OvaScience
- Kaila Krum William Blair
- Dr. KSS BioPub.co
- Madhu Kumar B. Riley Securities
- Ramesh Kumar OncoNova Therapeutics
L
- Pierre Labbé IMV Inc.
- Vikram Lamba Zosano Pharma Corp.
- Mark Landy Summer Street Research Partners
- Edward Lanphier Sangamo Therapeutics Inc.
- Matt Larew William Blair
- Sean Lavin BTIG Research
- Thomas LaVoy IsoRay Inc.
- Robert LeBoyer Noble Life Science Partners
- Jon LeCroy MKM Partners
- Kimberly Lee ThinkEquity, LLC
- Arlinda Lee Canaccord Genuity
- Endri Leno National Bank of Canada
- Alan Leong BioWatch News
- Jim Letourneau Big Picture Speculator BigPictureGuy
- Jeremy Levin Ovid Therapeutics Inc.
- Josh Levine MicroCap Investor
- David Lewis Morgan Stanley
- Chris Lewis Perceptive Advisors LLC
- Chris Lewis ROTH Capital Partners
- Howard Liang Leerink Partners LLC
- Marc Lichtenfeld Oxford Club
- Hendrik Liebers Probiodrug A.G.
- Chen Lin What Is Chen Buying? What Is Chen Selling?
- Ching-Yi Lin H.C. Wainwright & Co.
- Kevin Little 3D Signatures Inc.
- Dr. Douglas Loe Leede Financial Inc.
- Anthony (Tony) Lombardo Advaxis Inc.
- Jeffrey Loo Standard & Poor's
- Douglas Lowe Leede Financial Inc.
- David Lowe NeuroAssets
- David Luci Dipexium Pharmaceuticals Inc.
- Maria Luckevich Baxter International Inc.
- Tim Lugo William Blair
- Zack Lynch Neurotechnology Industry Organization
- Casey Lynch
M
- Ross Macdonald Cynata Therapeutics Ltd.
- George Mack BioDecade
- Gene Mack Brean Capital
- Geoff MacKay Organogenesis Holdings Inc.
- Mayank Mamtani B. Riley Securities
- Mayank Mamtani B. Riley Securities
- Moshe Manor Protalix Biotherapeutics Inc.
- Marc Mansour
- Christopher Marai Oppenheimer & Co.
- Brian Marckx Zacks Small-Cap Research
- Keith Markey Griffin Securities
- David Martin Bloom Burton & Co.
- Alex Martin Realm Therapeutics Inc.
- Sabrina Martucci Johnson Daré Bioscience Inc.
- Neil Maruoka Canaccord Genuity
- Mark Massaro BTIG Research
- Jeff Mathiesen Gemphire Therapeutics
- Mike Matson Needham & Co
- Shane Matte BioTuesdays
- Michael May Centre for Commercialization of Regenerative Medicine
- Alfred Maydorn Maydornreport
- Lawrence Mayer Celator Pharmaceuticals Inc.
- Scott McAuley Paradigm Capital
- Donald McCaffrey Resverlogix Corp.
- John McCamant Medical Technology Stock Letter
- Jason McCarthy Maxim Group
- Megan McCloskey Dow MLV & Co
- Henry McCusker Scimitar Equity
- Andrew McDonald Gemphire Therapeutics LifeSci Advisors
- Kristin McFarland Darrow Wealth Management
- Laura McGuigan
- Geoff Meacham Barclays
- Craig C. Mello University of Massachusetts Medical School
- Steve Mento Conatus Pharmaceuticals Inc.
- Eliana Merle UBS Securities
- Keith Merrcell Nu-Med Plus Inc.
- Mike Messinger ContraFect Corp.
- Sara Michelmore Brean Murray Carret & Co.
- Francois Michelon ENDRA Life Sciences
- Lauren Migliore Morningstar Equity Research
- Randy Milby
- Steven Miller Catalyst Pharmaceuticals Inc.
- David Miller Biotech Stock Research
- Jason Mills Canaccord Genuity
- Rick Mills Ahead of the Herd
- Miroslava Minkova Leerink Partners LLC
- Keyvan Mirsaeedi-Farahani Perceptive Advisors LLC
- James Molloy Alliance Global Partners
- Peter Molloy Race Oncology Limited
- Michael Moore VieMed
- Chris Moreau Miraculins Inc.
- Christopher Mori Deciphera Pharmaceuticals Inc.
- David Moskowitz ADMA Biologics Inc.
- Liana Moussatos Wedbush
- Tracey Mumford The Michael J. Fox Foundation for Parkinson's Research
- Amanda Murphy William Blair
N
- Ron Najafi NovaBay Pharmaceuticals Inc.
- Keay Nakae Chardan Capital Markets
- Keay Nakae Chardan Capital Markets
- Spencer Nam
- Michael Narachi Orexigen Therapeutics Inc.
- Richard Newitter Leerink Partners LLC
- John Newman Canaccord Genuity
- Weston Nichols Perceptive Advisors LLC
- Dr. David Nierengarten Wedbush
- Andrew Norris BioMed Reports
- David Novak Raymond James
- Colin Lee Novick CJ PARTNERS
- Bruce Nudell Credit Suisse
- Ran Nussbaum Pontifax
O
- Shawn Patrick O'Brien Cipher Pharmaceuticals Inc.
- Daniel O'Conner Advaxis Inc.
- Dan O'Connor OncoSec Medical Inc.
- Stephen O'Neil Hilliard Lyons
- Frank Oakes Stellar Biotechnologies Inc.
- Fred Ors IMV Inc.
- Kolin Ozonian Nobilis Health Corp.
P
- Anant Padmanabhan Goldman Sachs
- Steve Palmer AlphaNorth Asset Management
- Harry Palmin Acer Therapeutics
- Dr. Joseph Pantginis H.C. Wainwright & Co.
- Richard Parkes Deutsche Bank
- Andrew Partheniou Stifel
- Rich Pascoe Apricus Biosciences Inc.
- Joseph Patti Biota Pharmaceuticals
- Pamela Pavco RXi Pharmaceuticals Corp.
- Boris Peaker Oppenheimer & Co.
- Daniel Pearlstein M Partners
- Mario Pennisi Life Sciences Queensland
- Matthew Pepler Canaccord Genuity
- Adelene Perkins Infinity Pharmaceuticals Inc.
- Vincent Perrone Synthetic Biologics Inc.
- Tycho Peterson J.P. Morgan
- Antony Pfaffle CorMedix Inc.
- Rick Pierce MetaStat Inc.
- Dr. Elemer Piros Rodman & Renshaw
- William Plovanic Canaccord Genuity
- Jennifer Poland
- Eric Poma Molecular Templates
- Linda Pomeroy Edison Investment Research
- Konstantin Poukalov Kadmon Holdings Inc.
- Scott Power Morgans Financial Ltd.
- Brandon Primack SeeThruEquity
- Dennis Purcell Aisling Capital LLC
Q
- William Quirk Piper Jaffray & Co.
R
- Eden Rahim Next Edge Capital Theta Strategies Capital
- Erez Raphael LabStyle Innovations Corp.
- Joel Ray Davenport & Co.
- Jack Regan LexaGene Holdings Inc.
- Allan Reine Pieris Pharmaceuticals Inc.
- Michael Rice BioBlast Pharma LifeSci Advisors
- Alan Ridgeway Paradigm Capital
- Jeffrey Riley Synthetic Biologics Inc.
- Irina Rivkind Koffler Cantor Fitzgerald
- Stuart Roberts NDF Research
- Matthew Roden UBS Securities
- Shaun Rodriguez
- Marco Rodriguez Stonegate Capital Partners
- David Roman Goldman Sachs
- Kyle Rose Canaccord Genuity
- Jessica Rouseet Cure Pharmaceuticals Holding Corp.
- Charles Rowland Aurinia Pharmaceuticals Inc.
- Jami Rubin Goldman Sachs
- Adolfo Rueda Ladenburg Thalmann
- Morrie Ruffin Alliance for Regenerative Medicine
- Jason Russ Seeking Alpha
- Barbara Ryan
S
- Anthony Samaha LGC Capital
- Annabel Samimy Stifel
- Juan Sanchez Ladenburg Thalmann
- Glen Santangelo Credit Suisse
- Stephen Saunders
- John Savin Edison Investment Research
- Christopher Schaber Soligenix Inc.
- Thomas Schall ChemoCentryx Inc.
- Patricia Scheller Viveve Medical Inc.
- Doug Schenkel Cowen & Co.
- Eric Schmidt Cowen & Co.
- Chris Schott J.P. Morgan
- Lynn Seely Myovant Sciences Ltd.
- Phillip Seligman Standard & Poor's
- Dr. Ram Selvaraju H.C. Wainwright & Co.
- Joel Sendek Stifel
- Philip "Phil" Serlin BioLineRx Ltd.
- Sandesh Seth Actinium Pharmaceuticals Inc.
- Steven Shallcross Synthetic Biologics Inc.
- Chris Shelling Acer Therapeutics
- David Sherman LifeSci Capital
- Ascher Shmulewitz Therapix Biosciences Ltd.
- Bernard Siegel Genetics Policy Institute
- Ross Silver Sylva International Vista Partners
- Steve Silver KCSA Strategic Communications
- Jay Silverman BioInvest.com
- Simos Simeonidis Cowen & Co.
- Hartaj Singh Oppenheimer & Co.
- Matthijs Smith Canaccord Genuity
- Lawrence Solow CJS Securites
- John Sonnier William Blair
- Brad Spellberg Synthetic Biologics Inc.
- John Sperzel Chembio Diagnostic Systems Inc.
- Jeffrey Spurr JMP Securities
- Russell Stanley Echelon Wealth Partners
- Dewey Steadman Canaccord Genuity
- Chelsea Stellick iA Capital Markets
- Mike Step Ritter Pharmaceuticals Inc.
- Kristen Stewart Deutsche Bank
- Edward Stopke Sagient Research
- Shane Storey Wilson HTM Investment Group
- Senthil Sundaram Nightstar Therapeutics Plc
- Graig Suvannavejh Mizuho Bank
- Peter Suzdak Rexahn Pharmaceuticals Inc.
- Dan Swisher, Jr. Sunesis Pharmaceuticals Inc.
T
- Ajay Tandon SeeThruEquity
- Michael Taylor Deciphera Pharmaceuticals Inc.
- Ross Taylor CL King & Associates
- Matthew Taylor National Bank Financial
- Edward Tenthoff Piper Jaffray & Co.
- James Terwilliger Newport Coast Securities
- Michael Tong Wells Fargo & Co.
- Dan Trang Stonegate Securities
- John Tucker Sagient Research
- Jan Turek Therapix Biosciences Ltd.
- Chris Tyson ENDRA Life Sciences
U
- Dr. Andre Uddin Research Capital Corporation
V
- Gil Van Bokkelen Athersys Inc.
- Tyler Van Buren TD Cowen
- Guillaume van Renterghem UBS Securities
- Cary Vance Hansen Medical Inc.
- John Vandermosten Zacks Small-Cap Research
- Rohit Vanjani Oppenheimer & Co.
- Anthony Vendetti Maxim Group
- Alain Vertes NxR Biotechnologies GmbH
- Kim Vukhac CLSA
W
- Nick Waddell Cantech Letter
- Greg Wade Wedbush
- Jill Wahleithner Wasatch Funds
- Harlan Waksal Kadmon Holdings Inc.
- Jack Wallace
- Adam Walsh Stifel
- Ling Wang Chardan Capital Markets
- Stewart Washer Cynata Therapeutics Ltd.
- Robert Wasserman Dawson James Securities
- Michael Weinstein J.P. Morgan
- Brian Weinstein William Blair
- David Wells ENDRA Life Sciences
- Yaron Werber Citigroup
- Michael Werner Alliance for Regenerative Medicine
- Carol Werther H.C. Wainwright & Co.
- James West Midas Letter
- Brooks West Piper Jaffray & Co.
- Steven Wheen J.P. Morgan
- Edward White H.C. Wainwright & Co.
- Marcel Wijma The Daily Molecule (Van Leeuwenhoeck Research) Van Leeuwenhoeck Research
- Stephen Willey Stifel
- William Williams BriaCell Therapeutics Corp.
- Tory Williams
- Troy Wilson Kura Oncology Inc.
- Brian Wilson Bio-Wire
- Rick Wise Stifel
- Charles Wiseman BriaCell Therapeutics Corp.
- Nadine Wong Wong's Bio Tech Stock Report
- Scott Wong Wong's Bio Tech Stock Report
- Edward Woo Ascendiant Capital Markets
- Joanne Wuensch BMO Capital Markets
X
- Katherine Xu William Blair
Y
- Len Yaffe Stoc*Doc Partners
- Eun Yang Jefferies & Co.
- Craig Yeshion Perceptive Advisors LLC
- Thomas Yip H.C. Wainwright & Co.
- Scott Young Flexion Therapeutics Inc.
Z
- Saiid Zarrabian DelMar Pharmaceuticals Inc.
- George Zavoico B. Riley Securities
- Leonard Zehr
- Grant Zeng Zacks Investment Research Zacks Small-Cap Research
- Don Zinn Q-Labs
- Mark Zinski 21st Century Equity Research
- Alexander Zukiwski Arno Therapeutics Inc.
